Presentation is loading. Please wait.

Presentation is loading. Please wait.

Visit-to-visit variability of blood pressure and coronary heart disease, stroke, heart failure and mortality: results from the Antihypertensive and Lipid-Lowering.

Published bySylvia Houston Modified over 6 years ago

Similar presentations

Presentation on theme: "Visit-to-visit variability of blood pressure and coronary heart disease, stroke, heart failure and mortality: results from the Antihypertensive and Lipid-Lowering."— Presentation transcript:

1 Visit-to-visit variability of blood pressure and coronary heart disease, stroke, heart failure and mortality: results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)  Paul Muntner, Jeff Whittle, Amy I. Lynch, Lara M. Simpson, Paula Einhorn, Emily B. Levitan, Paul K. Whelton, William C. Cushman, Gail Louis, Barry R. Davis, Suzanne Oparil  Journal of the American Society of Hypertension  Volume 8, Issue 4, Pages e13-e14 (April 2014) DOI: /j.jash Copyright © Terms and Conditions

2 Journal of the American Society of Hypertension 2014 8, e13-e14DOI: (10.1016/j.jash.2014.03.025)
Copyright © Terms and Conditions

Download ppt "Visit-to-visit variability of blood pressure and coronary heart disease, stroke, heart failure and mortality: results from the Antihypertensive and Lipid-Lowering."

Similar presentations

U.S. Department of Health and Human Services National Institutes of Health National Heart, Lung, and Blood Institute Review of Heart Failure Events in.

U.S. Department of Health and Human Services National Institutes of Health National Heart, Lung, and Blood Institute Review of Heart Failure Events in.
The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial ALLHAT study overview Double-blind, randomized trial to determine whether.

The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial ALLHAT study overview Double-blind, randomized trial to determine whether.
1 Antihypertensive Trial Outcome Differences: Diuretic vs. Calcium Channel Blocker Compared to participants assigned to the diuretic, those assigned to.

1 Antihypertensive Trial Outcome Differences: Diuretic vs. Calcium Channel Blocker Compared to participants assigned to the diuretic, those assigned to.
Functional Analysis of the Neurofibromatosis Type 2 Protein by Means of Disease- Causing Point Mutations Renee P. Stokowski, David R. Cox The American.

Functional Analysis of the Neurofibromatosis Type 2 Protein by Means of Disease- Causing Point Mutations Renee P. Stokowski, David R. Cox The American.
Gene Preference in Maple Syrup Urine Disease Mary M. Nellis, Dean J. Danner The American Journal of Human Genetics Volume 68, Issue 1, Pages 232-237 (January.

Gene Preference in Maple Syrup Urine Disease Mary M. Nellis, Dean J. Danner The American Journal of Human Genetics Volume 68, Issue 1, Pages (January.
Agarose-Dextran Gels as Synthetic Analogs of Glomerular Basement Membrane: Water Permeability Jeffrey A. White, William M. Deen Biophysical Journal Volume.

Agarose-Dextran Gels as Synthetic Analogs of Glomerular Basement Membrane: Water Permeability Jeffrey A. White, William M. Deen Biophysical Journal Volume.
From: Visit-to-Visit Variability of Blood Pressure and Coronary Heart Disease, Stroke, Heart Failure, and Mortality: A Cohort Study Ann Intern Med. 2015;163(5):329-338.

From: Visit-to-Visit Variability of Blood Pressure and Coronary Heart Disease, Stroke, Heart Failure, and Mortality: A Cohort Study Ann Intern Med. 2015;163(5):
Increased placebo response in Hispanics vs non-Hispanics in nebivolol hypertension trials: A post-hoc pooled analysis  Thomas D. Giles, Henry Punzi, Madhuja.

Increased placebo response in Hispanics vs non-Hispanics in nebivolol hypertension trials: A post-hoc pooled analysis  Thomas D. Giles, Henry Punzi, Madhuja.
Pharmacist intervention for blood pressure control: medication intensification and adherence  Tyler Gums, Paul James, Barry Carter, Mark Vander Weg, Liz.

Pharmacist intervention for blood pressure control: medication intensification and adherence  Tyler Gums, Paul James, Barry Carter, Mark Vander Weg, Liz.
Colloquium on Therapy of Right Heart Failure

Colloquium on Therapy of Right Heart Failure
MP60-03 PROSTATE CANCER IN THE ELDERLY

MP60-03 PROSTATE CANCER IN THE ELDERLY
Hypertension-Lipid Connection: Introduction

Hypertension-Lipid Connection: Introduction
Thomas G. Pickering, MD, DPhil, William B. White, MD 

Thomas G. Pickering, MD, DPhil, William B. White, MD 
L. Julian Haywood, M. D. , Barry R. Davis, M. D. , Ph. D. , Linda B

L. Julian Haywood, M. D. , Barry R. Davis, M. D. , Ph. D. , Linda B
Volume 56, Issue 1, Pages (July 1969)

Volume 56, Issue 1, Pages (July 1969)
Effects of sodium-glucose co-transporter 2 inhibitors on blood pressure: A systematic review and meta-analysis  William L. Baker, PharmD, FCCP, Lindsay.

Effects of sodium-glucose co-transporter 2 inhibitors on blood pressure: A systematic review and meta-analysis  William L. Baker, PharmD, FCCP, Lindsay.
National Guidelines for Nursing Delegation

National Guidelines for Nursing Delegation
Adjunctive therapy with interferon-gamma for the treatment of pulmonary tuberculosis: a systematic review  X.-F. Gao, Z.-W. Yang, J. Li  International.

Adjunctive therapy with interferon-gamma for the treatment of pulmonary tuberculosis: a systematic review  X.-F. Gao, Z.-W. Yang, J. Li  International.
Copyright © 2000 American Medical Association. All rights reserved.

Copyright © 2000 American Medical Association. All rights reserved.
All-cause mortality by treatment group

All-cause mortality by treatment group

Similar presentations

Ads by Google